The unpublished Australian CEA assumed that SW-CAH is clinically analogous to medium chain acyl-CoA dehydrogenase (MCAD) deficiency in risk of crises that result in neurological impairment and disability. Here, ACADM is linked to medium chain acyl-CoA dehydrogenase deficiency.